Literature DB >> 27623015

Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Eduardo E Arteaga-Bracho1, Maria Gulinello2, Michael L Winchester3, Nandini Pichamoorthy3, Jenna R Petronglo3, Alicia D Zambrano4, Julio Inocencio5, Chirstopher D De Jesus1, Joseph O Louie5, Solen Gokhan3, Mark F Mehler6, Aldrin E Molero7.   

Abstract

The mutation in huntingtin (mHtt) leads to a spectrum of impairments in the developing forebrain of Huntington's disease (HD) mouse models. Whether these developmental alterations are due to loss- or gain-of-function mechanisms and contribute to HD pathogenesis is unknown. We examined the role of selective loss of huntingtin (Htt) function during development on postnatal vulnerability to cell death. We employed mice expressing very low levels of Htt throughout embryonic life to postnatal day 21 (Hdhd•hyp). We demonstrated that Hdhd•hyp mice exhibit: (1) late-life striatal and cortical neuronal degeneration; (2) neurological and skeletal muscle alterations; and (3) white matter tract impairments and axonal degeneration. Hdhd•hyp embryos also exhibited subpallial heterotopias, aberrant striatal maturation and deregulation of gliogenesis. These results indicate that developmental deficits associated with Htt functions render cells present at discrete neural foci increasingly susceptible to cell death, thus implying the potential existence of a loss-of-function developmental component to HD pathogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Degeneration; Development; Gliogenesis; Huntingtin; Huntington's disease; Loss-of-function; Maturation; Myelin; Neurogenesis; Pathogenesis

Mesh:

Substances:

Year:  2016        PMID: 27623015      PMCID: PMC5102778          DOI: 10.1016/j.nbd.2016.09.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  88 in total

1.  Quantitative neuropathological changes in presymptomatic Huntington's disease.

Authors:  E Gómez-Tortosa; M E MacDonald; J C Friend; S A Taylor; L J Weiler; L A Cupples; J Srinidhi; J F Gusella; E D Bird; J P Vonsattel; R H Myers
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

2.  Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

Authors:  Y Sun; A Savanenin; P H Reddy; Y F Liu
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

3.  Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study.

Authors:  D Stoffers; S Sheldon; J M Kuperman; J Goldstein; J Corey-Bloom; A R Aron
Journal:  Neurology       Date:  2010-04-13       Impact factor: 9.910

4.  NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1.

Authors:  Martina Metzler; Lu Gan; Tak Pan Wong; Lidong Liu; Jeffrey Helm; Lili Liu; John Georgiou; Yushan Wang; Nagat Bissada; Kevin Cheng; John C Roder; Yu Tian Wang; Michael R Hayden
Journal:  J Neurosci       Date:  2007-02-28       Impact factor: 6.167

5.  Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis.

Authors:  Juliette D Godin; Kelly Colombo; Maria Molina-Calavita; Guy Keryer; Diana Zala; Bénédicte C Charrin; Paula Dietrich; Marie-Laure Volvert; François Guillemot; Ioannis Dragatsis; Yohanns Bellaiche; Frédéric Saudou; Laurent Nguyen; Sandrine Humbert
Journal:  Neuron       Date:  2010-08-12       Impact factor: 17.173

6.  Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.

Authors:  Richard R Ribchester; Derek Thomson; Nigel I Wood; Tim Hinks; Thomas H Gillingwater; Thomas M Wishart; Felipe A Court; A Jennifer Morton
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

Review 7.  Huntington's disease. Part 2: treatment and management issues in juvenile HD.

Authors:  Aimee Aubeeluck; Helen Brewer
Journal:  Br J Nurs       Date:  2008 Feb 28-Mar 12

8.  Cortical inhibitory deficits in premanifest and early Huntington's disease.

Authors:  April L Philpott; Tarrant D R Cummins; Neil W Bailey; Andrew Churchyard; Paul B Fitzgerald; Nellie Georgiou-Karistianis
Journal:  Behav Brain Res       Date:  2015-09-28       Impact factor: 3.332

9.  Abnormal Weight and Body Mass Index in Children with Juvenile Huntington's Disease.

Authors:  Alexander Tereshchenko; Michael McHugh; Jessica K Lee; Pedro Gonzalez-Alegre; Kaitlin Crane; Jeffrey Dawson; Peg Nopoulos
Journal:  J Huntingtons Dis       Date:  2015

10.  RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.

Authors:  Adam Labadorf; Andrew G Hoss; Valentina Lagomarsino; Jeanne C Latourelle; Tiffany C Hadzi; Joli Bregu; Marcy E MacDonald; James F Gusella; Jiang-Fan Chen; Schahram Akbarian; Zhiping Weng; Richard H Myers
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more
  28 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

Review 2.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

3.  Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.

Authors:  Caitlin S Latimer; Margaret E Flanagan; Patrick J Cimino; Suman Jayadev; Marie Davis; Zachary S Hoffer; Thomas J Montine; Luis F Gonzalez-Cuyar; Thomas D Bird; C Dirk Keene
Journal:  J Huntingtons Dis       Date:  2017

Review 4.  Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.

Authors:  Sara Grassi; Paola Giussani; Laura Mauri; Simona Prioni; Sandro Sonnino; Alessandro Prinetti
Journal:  J Lipid Res       Date:  2019-12-23       Impact factor: 5.922

5.  Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.

Authors:  Costanza Ferrari Bardile; Marta Garcia-Miralles; Nicholas S Caron; Nirmala Arul Rayan; Sarah R Langley; Nathan Harmston; Ana Maria Rondelli; Roy Tang Yi Teo; Sabine Waltl; Lisa M Anderson; Han-Gyu Bae; Sangyong Jung; Anna Williams; Shyam Prabhakar; Enrico Petretto; Michael R Hayden; Mahmoud A Pouladi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-23       Impact factor: 11.205

6.  Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.

Authors:  Katherine E Vest; Brittany L Phillips; Ayan Banerjee; Luciano H Apponi; Eric B Dammer; Weiting Xu; Dinghai Zheng; Julia Yu; Bin Tian; Grace K Pavlath; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

7.  Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.

Authors:  Bryan Zeitler; Steven Froelich; Kimberly Marlen; David A Shivak; Qi Yu; Davis Li; Jocelynn R Pearl; Jeffrey C Miller; Lei Zhang; David E Paschon; Sarah J Hinkley; Irina Ankoudinova; Stephen Lam; Dmitry Guschin; Lexi Kopan; Jennifer M Cherone; Hoang-Oanh B Nguyen; Guijuan Qiao; Yasaman Ataei; Matthew C Mendel; Rainier Amora; Richard Surosky; Josee Laganiere; B Joseph Vu; Anand Narayanan; Yalda Sedaghat; Karsten Tillack; Christina Thiede; Annette Gärtner; Seung Kwak; Jonathan Bard; Ladislav Mrzljak; Larry Park; Taneli Heikkinen; Kimmo K Lehtimäki; Marie M Svedberg; Jenny Häggkvist; Lenke Tari; Miklós Tóth; Andrea Varrone; Christer Halldin; Andrea E Kudwa; Sylvie Ramboz; Michelle Day; Jyothisri Kondapalli; D James Surmeier; Fyodor D Urnov; Philip D Gregory; Edward J Rebar; Ignacio Muñoz-Sanjuán; H Steve Zhang
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

8.  Abnormal development of cerebellar-striatal circuitry in Huntington disease.

Authors:  Alexander V Tereshchenko; Jordan L Schultz; Joel E Bruss; Vincent A Magnotta; Eric A Epping; Peg C Nopoulos
Journal:  Neurology       Date:  2020-04-07       Impact factor: 9.910

9.  Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's disease.

Authors:  Mali Jiang; Xiaoyan Zhang; Hongshuai Liu; Jared LeBron; Athanasios Alexandris; Qi Peng; Hao Gu; Fanghan Yang; Yuchen Li; Ruiling Wang; Zhipeng Hou; Nicolas Arbez; Qianwei Ren; Jen-Li Dong; Emma Whela; Ronald Wang; Tamara Ratovitski; Juan C Troncoso; Susumu Mori; Christopher A Ross; Janghoo Lim; Wenzhen Duan
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

10.  Huntington's disease alters human neurodevelopment.

Authors:  Mariacristina Capizzi; Esther Aparicio; Monia Barnat; Susana Boluda; Doris Wennagel; Radhia Kacher; Rayane Kassem; Sophie Lenoir; Fabienne Agasse; Barbara Y Braz; Jeh-Ping Liu; Julien Ighil; Aude Tessier; Scott O Zeitlin; Charles Duyckaerts; Marc Dommergues; Alexandra Durr; Sandrine Humbert
Journal:  Science       Date:  2020-07-16       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.